RACHEL GOULD: Open Payments
NPI 1063056539 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,045 in 58 payments from 14 companies in 2025. Trend: 2023 $571 · 2024 $703 · 2025 $1,045
Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $353 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $142 |
| Janssen Biotech, Inc. | 3 | $130 |
| Janssen Scientific Affairs, LLC | 1 | $76 |
| Phathom Pharmaceuticals, Inc. | 9 | $69 |
| GENZYME CORPORATION | 2 | $48 |
| PFIZER INC. | 3 | $46 |
| Lilly USA, LLC | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Novo Nordisk Inc | 1 | $25 |
Products named: RINVOQ, XIFAXAN, TREMFYA, Linzess, VOQUEZNA, SKYRIZI, CREON, DUPIXENT.
Industry payments across IN — which companies pay providers there.
